/
Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company. Medtronic was founded in 1949 and today serves healthcare systems, physicians, clinicians, and patients in more than 150 countries worldwide.
$76.15
$1.81 (-2.32%)
Price from 26 days ago
17.76% operating margin is respectable but not wide. ROIC at 6.47%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 3.6%, steady but not accelerating.
Even for strong businesses, today's 21x P/E means the stock needs to keep delivering. There's no margin of safety if growth disappoints.
21.3x earnings, 18.2x FCF. Valuation is in a reasonable range. The main question is whether the business can re-accelerate or if current trajectory is already priced in.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$35.48B
▲ +3.6% YoY
Net Income (TTM)
$4.61B
▲ +26.8% YoY
Op. Margin
17.00%
▲ +1.9pp YoY
ROIC
6.61%
▲ +1.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$5.41B
▼ -0.3% YoY
Op. Cash Flow (TTM)
$7.29B
▲ +3.8% YoY
Net Debt
$19.75B
Cash & Equiv.
$8.38B
5Y CAGR: +3.0%
5Y CAGR: -2.9%
Continue Research